Topic
Orphan Drug Designation (ODD)
Global News
29 Jan 2021
US FDA grants orphan drug designation to Zydus Cadila’s Saroglitazar Mg
The drug is used for the treatment of patients with Primary Biliary Cholangitis (PBC), a liver disease Zydus Cadila said…
Global News
6 Nov 2020
XNK Therapeutics receives US orphan drug status
The status was received for NK cell-based immunotherapy in multiple myeloma XNK Therapeutics has received Orphan Drug Designation (ODD) from…